These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 1632813

  • 21. Irreversible binding and metabolism of propranolol by human liver microsomes--relationship to polymorphic oxidation.
    Shaw L, Lennard MS, Tucker GT, Bax ND, Woods HF.
    Biochem Pharmacol; 1987 Jul 15; 36(14):2283-8. PubMed ID: 3111480
    [Abstract] [Full Text] [Related]

  • 22. Metabolic activation of the new tricyclic antidepressant tianeptine by human liver cytochrome P450.
    Larrey D, Tinel M, Lettéron P, Maurel P, Loeper J, Belghiti J, Pessayre D.
    Biochem Pharmacol; 1990 Aug 01; 40(3):545-50. PubMed ID: 2383287
    [Abstract] [Full Text] [Related]

  • 23. Covalent binding of a reactive metabolite derived from propranolol and its active metabolite 4-hydroxypropranolol to hepatic microsomal proteins of the rat.
    Narimatsu S, Arai T, Watanabe T, Masubuchi Y, Horie T, Suzuki T, Ishikawa T, Tsutsui M, Kumagai Y, Cho AK.
    Chem Res Toxicol; 1997 Mar 01; 10(3):289-95. PubMed ID: 9084908
    [Abstract] [Full Text] [Related]

  • 24. Activation of 8-methoxypsoralen by cytochrome P-450. Enzyme kinetics of covalent binding and influence of inhibitors and inducers of drug metabolism.
    Mays DC, Hilliard JB, Wong DD, Gerber N.
    Biochem Pharmacol; 1989 May 15; 38(10):1647-55. PubMed ID: 2730678
    [Abstract] [Full Text] [Related]

  • 25. Activation of propranolol and irreversible binding to rat liver microsomes: strain differences and effects of inhibitors.
    Masubuchi Y, Narimatsu S, Suzuki T.
    Biochem Pharmacol; 1992 Feb 04; 43(3):635-7. PubMed ID: 1540217
    [Abstract] [Full Text] [Related]

  • 26. The role of metabolic activation by cytochrome P-450 in covalent binding of VP 16-213 to rat liver and HeLa cell microsomal proteins.
    van Maanen JM, de Ruiter C, de Vries J, Kootstra PR, Gobas F, Pinedo HM.
    Eur J Cancer Clin Oncol; 1985 Sep 04; 21(9):1099-106. PubMed ID: 4065181
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Metabolic activation of the tricyclic antidepressant amineptine--I. Cytochrome P-450-mediated in vitro covalent binding.
    Geneve J, Larrey D, Letteron P, Descatoire V, Tinel M, Amouyal G, Pessayre D.
    Biochem Pharmacol; 1987 Feb 01; 36(3):323-9. PubMed ID: 3814174
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Cytochrome P450 dependent N-hydroxylation of a guanidine (debrisoquine), microsomal catalysed reduction and further oxidation of the N-hydroxy-guanidine metabolite to the urea derivative. Similarity with the oxidation of arginine to citrulline and nitric oxide.
    Clement B, Schultze-Mosgau MH, Wohlers H.
    Biochem Pharmacol; 1993 Dec 14; 46(12):2249-67. PubMed ID: 8274159
    [Abstract] [Full Text] [Related]

  • 31. Monooxygenase-mediated activation of chlorotrianisene (TACE) in covalent binding to rat hepatic microsomal proteins.
    Juedes MJ, Bulger WH, Kupfer D.
    Drug Metab Dispos; 1987 Dec 14; 15(6):786-93. PubMed ID: 2893703
    [Abstract] [Full Text] [Related]

  • 32. Species differences in the covalent binding of [14C]tamoxifen to liver microsomes and the forms of cytochrome P450 involved.
    White IN, De Matteis F, Gibbs AH, Lim CK, Wolf CR, Henderson C, Smith LL.
    Biochem Pharmacol; 1995 Apr 18; 49(8):1035-42. PubMed ID: 7748182
    [Abstract] [Full Text] [Related]

  • 33. Metabolism of the "mixed" cytochrome P-450 inducer hexachlorobenzene by rat liver microsomes.
    Stewart FP, Smith AG.
    Biochem Pharmacol; 1986 Jul 01; 35(13):2163-70. PubMed ID: 3729973
    [Abstract] [Full Text] [Related]

  • 34. Role of N-methylolpentamethylmelamine in the metabolic activation of hexamethylmelamine.
    Ames MM, Sanders ME, Tiede WS.
    Cancer Res; 1983 Feb 01; 43(2):500-4. PubMed ID: 6401219
    [Abstract] [Full Text] [Related]

  • 35. The covalent binding of cyclosporin A to rat liver macromolecules in vivo and in vitro: the role of cytochrome P-450.
    Nagelkerke JF, Tijdens RB, Schwarz EP, Winters MF, Paul LC, Mulder GJ.
    Toxicology; 1987 Dec 14; 47(3):277-84. PubMed ID: 3424383
    [Abstract] [Full Text] [Related]

  • 36. Enzyme-mediated covalent binding of hydralazine to rat liver microsomes.
    Streeter AJ, Timbrell JA.
    Drug Metab Dispos; 1983 Dec 14; 11(3):179-83. PubMed ID: 6135572
    [Abstract] [Full Text] [Related]

  • 37. Effect of hyperthyroidism on the in vitro metabolism and covalent binding of 1,1-dichloroethylene in rat liver microsomes.
    Gunasena GH, Kanz MF.
    J Toxicol Environ Health; 1997 Oct 10; 52(2):169-88. PubMed ID: 9310148
    [Abstract] [Full Text] [Related]

  • 38. Covalent binding of [14C]methoxychlor metabolite(s) to rat liver microsomal components.
    Bulger WH, Temple JE, Kupfer D.
    Toxicol Appl Pharmacol; 1983 May 10; 68(3):367-74. PubMed ID: 6857671
    [Abstract] [Full Text] [Related]

  • 39. Selective 3-hydroxylation deficiency of lidocaine and its metabolite in Dark Agouti rats.
    Masubuchi Y, Umeda S, Chiba M, Fujita S, Suzuki T.
    Biochem Pharmacol; 1991 Jul 15; 42(3):693-5. PubMed ID: 1859470
    [Abstract] [Full Text] [Related]

  • 40. Differences in cytochrome P450-mediated biotransformation of 1,2-dichlorobenzene by rat and man: implications for human risk assessment.
    Hissink AM, Oudshoorn MJ, Van Ommen B, Haenen GR, Van Bladeren PJ.
    Chem Res Toxicol; 1996 Dec 15; 9(8):1249-56. PubMed ID: 8951226
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.